You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API EFAVIRENZ


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing EFAVIRENZ

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Bristol-Myers Squibb Pharma Company SUSTIVA efavirenz 0056-0470 FD&C BLUE NO. 2
Bristol-Myers Squibb Pharma Company SUSTIVA efavirenz 0056-0470 FERRIC OXIDE YELLOW
Bristol-Myers Squibb Pharma Company SUSTIVA efavirenz 0056-0470 GELATIN
Bristol-Myers Squibb Pharma Company SUSTIVA efavirenz 0056-0470 LACTOSE MONOHYDRATE
Bristol-Myers Squibb Pharma Company SUSTIVA efavirenz 0056-0470 MAGNESIUM STEARATE
Bristol-Myers Squibb Pharma Company SUSTIVA efavirenz 0056-0470 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing EFAVIRENZ

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc efavirenz 0378-2233 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc efavirenz 0378-2233 CROSCARMELLOSE SODIUM
Mylan Pharmaceuticals Inc efavirenz 0378-2233 FERRIC OXIDE RED
Mylan Pharmaceuticals Inc efavirenz 0378-2233 FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc efavirenz 0378-2233 HYDROXYPROPYL CELLULOSE
Mylan Pharmaceuticals Inc efavirenz 0378-2233 HYPROMELLOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for EFAVIRENZ

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: CARMINIC ACID

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

EFAVIRENZ drug variants not containing CROSCARMELLOSE SODIUM

Company Ingredient NDC
Bristol-Myers Squibb Pharma Company efavirenz 0056-0470
Rising Pharma Holdings Inc efavirenz 64980-406
Aurobindo Pharma Limited efavirenz 65862-104
Aurobindo Pharma Limited efavirenz 65862-774
Teva Pharmaceuticals USA Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 0093-5234
REMEDYREPACK INC efavirenz, emtricitabine and tenofovir disoproxil fumarate 70518-2905
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CROSPOVIDONE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

EFAVIRENZ drug variants not containing FERRIC OXIDE YELLOW

Company Ingredient NDC
Physicians Total Care Inc efavirenz 54868-4668
Camber Pharmaceuticals Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 31722-736
Macleods Pharmaceuticals Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 33342-138
Laurus Labs Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 42385-915
American Health Packaging efavirenz, emtricitabine and tenofovir disoproxil fumarate 60687-706
Aurobindo Pharma Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 65862-497
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

EFAVIRENZ drug variants not containing LACTOSE MONOHYDRATE

Company Ingredient NDC
Camber Pharmaceuticals Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 31722-736
Macleods Pharmaceuticals Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 33342-138
Laurus Labs Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 42385-915
American Health Packaging efavirenz, emtricitabine and tenofovir disoproxil fumarate 60687-706
Aurobindo Pharma Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 65862-497
Cipla USA Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 69097-210
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 200

Excipient focus: POLOXAMER 407

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

EFAVIRENZ drug variants containing POLYETHYLENE GLYCOL 3350

Company Ingredient NDC
Teva Pharmaceuticals USA Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 0093-5234
Camber Pharmaceuticals Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 31722-736
Macleods Pharmaceuticals Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 33342-138
American Health Packaging efavirenz, emtricitabine and tenofovir disoproxil fumarate 60687-706
Aurobindo Pharma Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 65862-497
REMEDYREPACK INC efavirenz, emtricitabine and tenofovir disoproxil fumarate 70518-2905
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYVINYL ALCOHOL

EFAVIRENZ drug variants containing POLYVINYL ALCOHOL

Company Ingredient NDC
Teva Pharmaceuticals USA Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 0093-5234
Camber Pharmaceuticals Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 31722-736
Macleods Pharmaceuticals Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 33342-138
Laurus Labs Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 42385-915
American Health Packaging efavirenz, emtricitabine and tenofovir disoproxil fumarate 60687-706
Aurobindo Pharma Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 65862-497
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

EFAVIRENZ drug variants containing SILICON DIOXIDE

Company Ingredient NDC
Bristol-Myers Squibb Pharma Company efavirenz 0056-0470
Rising Pharma Holdings Inc efavirenz 64980-406
Aurobindo Pharma Limited efavirenz 65862-104
Aurobindo Pharma Limited efavirenz 65862-774
Teva Pharmaceuticals USA Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 0093-5234
REMEDYREPACK INC efavirenz, emtricitabine and tenofovir disoproxil fumarate 70518-2905
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

EFAVIRENZ drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Bristol-Myers Squibb Pharma Company efavirenz 0056-0470
Rising Pharma Holdings Inc efavirenz 64980-406
Aurobindo Pharma Limited efavirenz 65862-104
Teva Pharmaceuticals USA Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 0093-5234
REMEDYREPACK INC efavirenz, emtricitabine and tenofovir disoproxil fumarate 70518-2905
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: STARCH, CORN

Excipient focus: TALC

EFAVIRENZ drug variants containing TALC

Company Ingredient NDC
Teva Pharmaceuticals USA Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 0093-5234
Camber Pharmaceuticals Inc efavirenz, emtricitabine and tenofovir disoproxil fumarate 31722-736
Macleods Pharmaceuticals Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 33342-138
Laurus Labs Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 42385-915
American Health Packaging efavirenz, emtricitabine and tenofovir disoproxil fumarate 60687-706
Aurobindo Pharma Limited efavirenz, emtricitabine and tenofovir disoproxil fumarate 65862-497
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TITANIUM DIOXIDE

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group